{"items": "8", "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish", "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.", "feed": [{"title": "Illumina: Company Investigated by the Portnoy Law Firm - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/09/g34251451/illumina-company-investigated-by-the-portnoy-law-firm", "time_published": "20230905T194729", "authors": ["Globe Newswire"], "summary": "Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Sept. 05, 2023 ( GLOBE NEWSWIRE ) -- The Portnoy Law Firm advises Illumina, Inc. ( \"Illumina\" or \"the Company\" ) ILMN investors that the firm has initiated an investigation into possible ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.00241, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.608634", "ticker_sentiment_score": "-0.057372", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Is Illumina Stock Trading Lower Today? - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/news/large-cap/23/09/34242404/why-is-illumina-stock-trading-lower-today", "time_published": "20230905T163731", "authors": ["Vandana Singh"], "summary": "Illumina Inc ILMN shares are trading lower after the company appointed Jacob Thaysen as its new CEO, roughly three months after the company parted ways with Francis deSouza.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/09/05/ilmn.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.030988, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.211191", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.716023", "ticker_sentiment_score": "-0.310279", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Illumina names new CEO months after Icahn proxy fight over Grail deal", "url": "https://www.cnbc.com/2023/09/05/illumina-names-ceo-jacob-thaysen-after-icahn-proxy-fight-over-grail.html", "time_published": "20230905T154629", "authors": ["Annika Kim Constantino"], "summary": "The announcement comes after a proxy fight with activist investor Carl Icahn, which ended with Illumina's former CEO Francis deSouza voluntarily stepping down.", "banner_image": "https://image.cnbcfm.com/api/v1/image/106936357-16305276182021-09-01t195824z_1778252698_rc26hp93su6c_rtrmadp_0_illumina-results.jpeg?v=1693928789&w=1920&h=1080", "source": "CNBC", "category_within_source": "Business", "source_domain": "www.cnbc.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.0, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.776097", "ticker_sentiment_score": "0.228528", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "EXEL vs. ILMN: Which Stock Is the Better Value Option?", "url": "https://www.zacks.com/stock/news/2144937/exel-vs-ilmn-which-stock-is-the-better-value-option", "time_published": "20230905T154007", "authors": ["Zacks Equity Research"], "summary": "Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Exelixis ( EXEL Quick QuoteEXEL - ) or Illumina ( ILMN Quick QuoteILMN - ) . But which of these two stocks presents investors with the better value opportunity right now?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default60.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.769861"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.466227, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "EXEL", "relevance_score": "0.686739", "ticker_sentiment_score": "0.580969", "ticker_sentiment_label": "Bullish"}, {"ticker": "ILMN", "relevance_score": "0.622414", "ticker_sentiment_score": "0.560052", "ticker_sentiment_label": "Bullish"}]}, {"title": "Illumina Names Jacob Thaysen as New CEO", "url": "https://www.wsj.com/business/c-suite/illumina-names-new-chief-executive-efe5ad92", "time_published": "20230905T153300", "authors": ["Chris Wack"], "summary": "Jacob Thaysen was named to the role after Francis deSouza resigned from the gene-sequencing maker in June amid a fight with regulators.", "banner_image": "https://images.wsj.net/im-846779?width=700&height=467", "source": "Wall Street Journal", "category_within_source": "Business", "source_domain": "www.wsj.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.128863, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.947069", "ticker_sentiment_score": "-0.230864", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Illumina names Agilent exec Jacob Thaysen as CEO", "url": "https://www.reuters.com/business/illumina-names-agilent-exec-jacob-thaysen-ceo-2023-09-05/", "time_published": "20230905T114533", "authors": ["Reuters"], "summary": "A sign at the front entrance to the global headquarters of Illumina is pictured in San Diego, California, U.S., November 28, 2022. REUTERS/Mike Blake/File Photo Acquire Licensing Rights", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/VVGTP5JJ75PJLPE54PQA3LLPR4.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.078331, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.355588", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.644033", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer - PR Newswire", "url": "https://www.prnewswire.com/news-releases/illuminas-board-appoints-jacob-thaysen-phd-as-its-new-chief-executive-officer-301917362.html", "time_published": "20230905T113000", "authors": [], "summary": "Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.303872, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.04872", "ticker_sentiment_score": "0.000996", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.04872", "ticker_sentiment_score": "0.106039", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.04872", "ticker_sentiment_score": "0.106039", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.375016", "ticker_sentiment_score": "0.538754", "ticker_sentiment_label": "Bullish"}]}, {"title": "Advancements in Genome Sequencing Propel Global RNA Sequencing Market Growth to 2030", "url": "https://www.prnewswire.com/news-releases/advancements-in-genome-sequencing-propel-global-rna-sequencing-market-growth-to-2030-301916843.html", "time_published": "20230904T174500", "authors": ["Research and Markets"], "summary": "DUBLIN, Sept. 4, 2023 /PRNewswire/ -- The \"RNA Sequencing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user and Region ( North America, Europe, Asia Pacific, Latin America and Middle East and Africa ) \" ...", "banner_image": "https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.382501, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.029951", "ticker_sentiment_score": "0.125733", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIO", "relevance_score": "0.029951", "ticker_sentiment_score": "0.125733", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.05986", "ticker_sentiment_score": "0.134004", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.05986", "ticker_sentiment_score": "0.15301", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TMO", "relevance_score": "0.029951", "ticker_sentiment_score": "0.125733", "ticker_sentiment_label": "Neutral"}]}]}